Antiepileptic Drug Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos
Epilepsy is a neurological disorder in which
brain activity becomes abnormal, causing seizures or periods of unusual
behavior, sensations, and sometimes loss of awareness. Anti-epileptic drugs (AEDs) work by changing the levels of
chemicals in your brain. They do not cure epilepsy but can stop seizures from happening.
Thus, a growing development of the new drugs coupled with the increasing
efforts in the research and development of more specific and effective drugs is
driving the global antiepileptic drug market. Furthermore, as per the World
Health Organization (WHO), around 50 million people worldwide have epilepsy,
making it one of the most common neurological diseases globally. Additionally,
increasing incidences of other neurological disorder and prenatal injuries are
the factors that contribute to the surging epileptic cases and induces the
demand for better antiepileptic treatments.
Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=22772
According to UnivDatos Market Insights (UMI)’ research
report “Global Antiepileptic
Drug Market Analysis, 2021”, the market is projected to grow at a CAGR of ~2% during 2021-27F.
Based on the drug class, the market is segmented into the first generation, second generation, and third generation. Second-generation drugs held a significant share in the antiepileptic drug market in 2020. This is due to their effectiveness in dealing with the slowing brain impulse and controlling the seizures. Furthermore, the growing approval and launch of new and improved drugs are further driving the market.
Based on the
distribution channel, the market is segmented into retail
pharmacies, hospital pharmacies, and online pharmacies. The online pharmacy
segment is expected to witness significant CAGR owing to the growing
penetration of e-pharmacy platforms across the world coupled with increasing
awareness regarding services offered by e-pharmacy. Furthermore, the growing
focus on digitization and rising internet penetration in developing are some
other key factors driving the market.
Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=22772
North America to Grab
Lion’s Share, and witnessed Explicit Growth
For a better understanding of the market
adoption of the antiepileptic drug market, the market is analyzed based on its
worldwide presence in the countries such as North America (United States,
Canada, and Rest of North America), Europe (Germany, France, Italy, Spain,
United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India,
Australia, and Rest of APAC), and Rest of World. North America constitutes a
major market for the antiepileptic drug industry owing to the increasing
prevalence of epilepsy. It's estimated that about 1.2 percent of U.S. people
have active epilepsy. Furthermore, the presence of well-established market
players and a developed healthcare ecosystem is expected to contribute
significantly region’s steady growth during the forecast period. North America is
expected to skyrocket with a steady CAGR during the forecast period as stated
in UnivDatos Market Insights (UMI)’ research
report “Global Antiepileptic Drug Market Analysis, 2021”.
For more informative information, please visit
us – https://univdatos.com/report/antiepileptic-drug-market/
According
to UnivDatos Market Insights (UMI)’,
the key players with a considerable market share in the Antiepileptic Drug Market
include Novartis AG, GlaxoSmithKline Plc, Johnson &
Johnson Service, Inc., Teva Pharmaceutical Industries Ltd., Pfizer Inc.,
Zogenix, Dr. Reddy's Laboratories Ltd., Alkem Labs, SK Biopharmaceuticals, and
Eisai Co., among
others. The players are focused on launching products for gaining customers'
traction and expanding their geographical reach to get a competitive edge in
the industry.
“Global Antiepileptic
Drug Market Analysis, 2021” provides comprehensive qualitative and
quantitative insights on the industry potential, key factors impacting sales
and purchase decisions, hotspots, and opportunities available for Antiepileptic
Drug providers across the Globe. Moreover, the report also encompasses the key
strategic imperatives for success for competitors along with strategic
factorial indexing measuring competitors’ capabilities on 16 parameters. This
will help companies in the formulation of go to Market Strategies and
identifying the blue ocean for its offerings.
For more informative information, please visit
us – https://univdatos.com/report/antiepileptic-drug-market/
Market Segmentation:
1. By Drug Class (First
Generation, Second Generation, and Third Generation)
2. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies)
3.
By Region (North America,
Europe, Asia-Pacific, Rest of the World)
4.
By Company (Novartis AG, GlaxoSmithKline Plc, Johnson &
Johnson Service, Inc., Teva Pharmaceutical Industries Ltd., Pfizer Inc.,
Zogenix, Dr. Reddy's Laboratories Ltd., Alkem Labs, SK Biopharmaceuticals, and
Eisai Co.)
Key
questions answered in the study:
1.
What are the current and future trends
of the Antiepileptic Drug industry?
2.
How the industry has been evolving in
terms of drug class and distribution channel?
3.
How the competition has been shaping
across the countries followed by their comparative factorial indexing?
4.
What are the key growth drivers and
challenges for the Antiepileptic Drug industry?
5.
What are the customer orientation,
purchase behavior, and expectations from the Antiepileptic Drug firms across
various regions?
Table
of Content –
1 MARKET INTRODUCTION
2 RESEARCH METHODOLOGY OR ASSUMPTION
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 GLOBAL ANTIEPILEPTIC DRUG MARKET COVID-19
IMPACT
6 GLOBAL ANTIEPILEPTIC DRUG MARKET REVENUE,
2019-2027F
7 MARKET INSIGHTS BY DRUG CLASS
8 MARKET INSIGHTS BY DISTRIBUTION CHANNEL
9 MARKET INSIGHTS BY REGION
10 ANTIEPILEPTIC DRUG MARKET DYNAMICS
11 ANTIEPILEPTIC DRUG MARKET OPPORTUNITIES
12 ANTIEPILEPTIC DRUG MARKET TRENDS
13 LEGAL & REGULATORY FRAMEWORK
14 DEMAND AND SUPPLY-SIDE ANALYSIS
15 VALUE CHAIN ANALYSIS
16 COMPETITIVE SCENARIO
17 COMPANY PROFILED
18 DISCLAIMER
Browse Other Related Research Reports from UnivDatos
Market Insights
·
Patient
Self-Service Kiosk Market to Reach US$ 1,637.5 Million by 2026 Globally | CAGR:
16.2%|
·
Precision
Medicine Market to Reach US$ 105.6 Billion by 2026, Globally |CAGR: 9.9%|
·
Body
Temperature Scanner Device Market to Exceed US$ 1 Billion by 2026, Globally
|CAGR: 8.8%|
·
Ophthalmic
Devices Market to Reach US$ 46.3 Billion by 2026, Globally |CAGR: 5.2%|
Labels: Antiepileptic Drug Market, Healthcare
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home